Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Leucine zipper and EF-hand containing transmembrane protein 1 (LETM1) is a mitochondrial inner membrane protein that functions primarily as a Ca²⁺/H⁺ antiporter and possibly as a K⁺/H⁺ exchanger. It is important for mitochondrial calcium efflux, potassium homeostasis, tubular mitochondrial morphology, cristae structure, and overall cellular viability. LETM1 is evolutionarily conserved in eukaryotes and essential for embryonic development in model organisms. *LETM1* gene deletion or mutation causes Wolf-Hirschhorn syndrome, characterized by developmental delay, seizures, and craniofacial abnormalities. The exact mechanisms of transport and regulation remain under study, but LETM1's hexameric structure and its role in proton gradient–dependent calcium movement are key features identified to date.
Potential drugs would modulate mitochondrial ion transport by altering Ca²⁺/H⁺ or K⁺/H⁺ exchange—affecting mitochondrial homeostasis, calcium signaling, apoptosis, or cell metabolism.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Leucine zipper and EF-hand containing transmembrane protein 1 (LETM1).